Centessa agrees to $38/share Lilly buyout; R&D spend surges 79% on Orexin trials
Filed May 5, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 14, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade CNTA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 2, 2026 4:54 AM